--This Event is Sold Out!--
Rick Doblin, Charles Grob, and Alicia Danforth
invite you to
Turning on a Light: Understanding Psychedelic Therapy
Saturday, November 15, 2014
$150 Dinner and Reception, Party of One
$250 Dinner and Reception, Party of Two
Price includes dinner, wine, conversation and a short presentation
by Rick Doblin, Ph.D., MAPS Founder and Executive Director,
and researchers Charles Grob, M.D. and Alicia Danforth, Ph.D.
There are still tickets available for our November 13 event in Culver City.
Private Rooftop Garden Club and Hummingbird & Butterfly Sanctuary at Petit Ermitage
8822 Cynthia Street, West Hollywood, CA
Colman Family Farms Baby Lettuce with Heirloom Tomatoes
Chef's Vegetarian Soup
Herb Roasted Chicken
Seasonal Vegetable Risotto
Crisp Fingerling Potatoes
Seasonal Market Vegetables
A Selection of Seasonal Fruits and Freshly Baked Cookies
Fine wines and craft beer served before and during dinner.
Charles Grob, M.D., and Alicia Danforth, Ph.D., are investigating the efficacy of MDMA-assisted psychotherapy in treating social anxiety in adults on the autism spectrum at Los Angeles Biomedical Research Institute at Harbor UCLA. Dr. Grob is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine. He received the first FDA approval for clinical research with MDMA, studied long-term ayahuasca use in Brazil, and examined the effects of psilocybin in advanced-stage cancer patients with severe anxiety. Dr. Danforth recently completed her Ph.D. research with a study of adults on the autism spectrum who found that self-medicating with "MDMA and/or Ecstasy" seemed to reduce their social anxiety.
Rick Doblin, Ph.D., founder and executive director of MAPS, is widely known as one of the leading experts on psychedelic research policy, funding and advocacy.
The Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization, is working on novel approaches to some of the world's most challenging mental health issues, such as PTSD, and social anxiety related to autism and end-of-life. MAPS is sponsoring Dr. Grob and Dr. Danforth's study, and needs to raise just over $410,000 in support of this ground breaking research.